The International Journal of Tuberculosis and Lung Disease

Late Onset Pott's paraplegia [Editorial]
pp. 387-388(2)
Author: Dwyer, Anthony P.

The annual risk of infection with Mycobacterium tuberculosis in England and Wales since 1901
pp. 389-396(8)
Authors: Vynnycky, E.; Fine, P. E. M.

Implementation of universal directly observed therapy at a New York City hospital and evaluation of an out-patient directly observed therapy program
pp. 397-404(8)
Authors: Salomon, N.; Perlman, D. C.; Rubenstein, A.; Mandelman, D.; McKinley, F. W.; Yancovitz, S. R.

Anti-tuberculosis drug resistance in Madagascar in 1994–1995
pp. 405-410(6)
Authors: Chanteau, S.; Rasolofo, V.; Ramarokoto, H.; Rasolonavalona, T.; Ratsirahonana, O.; Ratsitorahina, M.; Rakotomanana, F.; Boisier, P.; Cauchoix, B.; Aurégan, G.

Bioavailability of Chinese rifapentine during a clinical trial in Hong Kong
pp. 411-416(6)
Authors: Tam, C. M.; Chan, S. L.; Lam, C. W.; Dickinson, J. M.; Mitchison, D. A.

Osteitis caused by Bacille Calmette-Guérin vaccination: an emergent problem in Chile?
pp. 417-421(5)
Authors: Castro-Rodríguez, J. A.; González, R.; Girardi, G.

CD4⁺ T-lymphocytopenia in severe pulmonary tuberculosis without evidence of human immunodeficiency virus infection
pp. 422-426(5)
Authors: Pilheu, J. A.; De Salvo, M. C.; Gonzalez, J.; Rey, D.; Elias, M. C.; Ruppi, M. C.

Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand
pp. 427-434(8)
Authors: Yanai, H.; Uthaivoravit, W.; Mastro, T. D.; Limpakarnjanarat, K.; Sawanpanyalert, P.; Morrow Jr., R. H.; Nieburg, P.

Serological markers predicting tuberculosis in human immunodeficiency virus-infected patients
pp. 435-440(6)
Authors: Amicosante, M.; Richeldi, L.; Monno, L.; Cuboni, A.; Tartoni, P. L.; Angarano, G.; Orefici, G.; Saltini, C.

Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults
pp. 441-445(5)
Authors: Okwera, A.; Johnson, J. L.; Vjecha, M. J.; Wolski, K.; Whalen, C. C.; Hom, D.; Huebner, R.; Mugerwa, R. D.; Ellner, J. J.

Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis
pp. 446-453(8)
Authors: Johnson, J. L.; Okwera, A.; Vjecha, M. J.; Byekwaso, F.; Nakibali, J.; Nyole, S.; Milberg, J.; Aisu, T.; Whalen, C. C.; Mugerwa, R. D.; Ellner, J. J.

Rapid and improved recovery rate of Mycobacterium tuberculosis in Mycobacteria Growth Indicator Tube combined with solid Löwenstein Jensen medium
pp. 454-459(6)
Authors: Rivera, A. B.; Tupasi, T. E.; Grimaldo, E. R.; Cardano, R. C.; Co, V. M.

Activity of KRM 1648 or rifabutin alone or in combination with clarithromycin against Mycobacterium avium complex in human alveolar macrophages
pp. 460-467(8)
Authors: Suzuki, K.; Tsuyuguchi, K.; Matsumoto, H.; Yamamoto, T.; Hashimoto, T.; Tanaka, E.; Amitani, R.; Kuze, F.

Late onset paraplegia—a sequela to Pott's disease. A report on imaging, prevention and management [Case Report]
pp. 468-473(6)
Authors: Rajeswari, R.; Ranjani, R.; Santha, T.; Sriram, K.; Prabhakar, R.

Unusual miliary tuberculosis presenting with generalized lymphadenopathy and abdominal involvement [Case Report]
pp. 474-476(3)
Authors: Köylü, R.; Tozkoparan, E.; Pabuşçu, Y.; Çiftçi, F.; Bilgiç, H.; Seber, O.

Abcès cérébraux au cours d'une miliaire tuberculeuse: à propos d'un cas et revue de la littérature [Case Report]
pp. 477-481(5)
Authors: Benzarti, M.; Jerray, M.; Souissi, J.; Hayouni, A.; Garrouche, A.; Klabi, N.

Correspondence
pp. 482-486(5)